Rezultati pretraživanja
  1. 4. velj
    Prikaži ovu nit
  2. 15. lip 2019.
    Odgovor korisniku/ci

    I suppose there is a small chance of that, but if the trial is rejected due to lack of placebo data, shame on regulators, especially since Optune was approved based on a single arm. SOC survival in GBM is well documented and the results aren’t pretty. It’s an

  3. Prikaži ovu nit
  4. 28. velj 2019.

    For I want to honor Neil Caesar who died last year from a Mycobaterium abscessus . We must improve our research on so that cases like my dad's don't continue to rise.

  5. 18. lis 2019.
  6. May is hamartoma tumor syndrome awareness month. Educate yourself on the signs: macrocephaly, personal or family history of cancer, and/or . Follow the screening guidelines.

  7. 29. svi 2019.

    ideaXme with Patricia Weltin, Founder, Beyond the Diagnosis , nonprofit organization uniting art and science to inspire research and innovative treatments for people living with rare and neglected diseases -

  8. Ultra‐orphan lysosomal storage diseases: A cross‐sectional quantitative analysis of the natural history of alpha‐mannosidosis

  9. 28. velj 2019.

    Great blog on rare and orphan disease pharmaceuticals from my colleagues today on

  10. 17. stu 2019.
  11. 22. svi 2019.

    My name is Julie Solis and I'm a in . Our community group strives to bring awareness and resources to this . Please call me if you have questions, (661)404-0196.

  12. 9. sij 2019.

    Kicking off Wed morning at with the panel with David Snow Chief Business Officer at

  13. 26. kol 2019.

    When it comes to uncommon () conditions, it’s an Olympian challenge for doctors to connect the dots. In , the response “I don’t know” is now an act of .

  14. 6. lis 2019.

    It's unfortunate but it's true, isn't it? You're thinking you want to do one thing but the body does another...

  15. 15. sij 2019.

    And 25/61 drug approvals in 2018 were for !

    Prikaži ovu nit
  16. This is how pharmaceutical industry financial modelers think about your rare disease.

  17. 14. stu 2019.

    Let's try to be patient with ourselves. As this quote states, we are all unique and we all have our, one of a kind, timeline...

  18. 13. stu 2019.

    Our CEO, Krishnan Nandabalan, was pleased to address the World Orphan Drug Congress about the uses of artificial intelligence and machine learning to drive for rare disease treatments.

  19. 12. tra 2019.

    day 2 Some very interesting therapeutics coming through in from small biotech. Financial models still difficult. Watching Jeff Ajmer, Biomarin, talking about funding Gene Therapy and enable broad access

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.